PMEDF (QScreen AI) PEG Ratio: 0.00 (As of Jul. 01, 2026)


What is QScreen AI PEG Ratio?

QScreen AI PMEDF +57.06% PEG Ratio is 0.00 as of Jul. 01, 2026. The stock has 1 warning sign investors should review. Among 207 Medical Devices & Instruments companies, QScreen AI ranks worse than 483091.3% on this metric.

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, QScreen AI's PE Ratio without NRI is 0.00. QScreen AI's 5-Year EBITDA growth rate is 23.00%. Therefore, QScreen AI's PEG Ratio for today is 0.00.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for QScreen AI's PEG Ratio or its related term are showing as below:



PMEDF's PEG Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.03
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


QScreen AI  (OTCPK:PMEDF) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


QScreen AI PEG Ratio Related Terms


QScreen AI PEG Ratio Historical Data

* Premium members only.

The historical data trend for QScreen AI's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QScreen AI PEG Ratio Chart

QScreen AI Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
PEG Ratio
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

QScreen AI Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PMEDF vs ABT, SYK, MDT: PEG Ratio Comparison

For the Medical Devices subindustry, QScreen AI's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QScreen AI PEG Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QScreen AI's PEG Ratio distribution charts can be found below:

* The bar in red indicates where QScreen AI's PEG Ratio falls into.



QScreen AI PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

QScreen AI's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/23.00
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Frequently Asked Questions Learn more about PEG Ratio →
What does a PEG Ratio of 0.00 mean?
QScreen AI (PMEDF) has a PEG Ratio of 0.00 as of Jul. 01, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on QScreen AI and its competitors. According to the industry distribution chart, QScreen AI ranks #999999 out of 207 companies in the Medical Devices & Instruments industry.
Is QScreen AI's PEG Ratio too high?
QScreen AI's current PEG Ratio is 0.00. Based on the distribution chart, QScreen AI ranks #999999 out of 207 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does QScreen AI's PEG Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, QScreen AI ranks #999999 out of 207 companies for PEG Ratio. This places QScreen AI in the lower half of its industry. The industry median PEG Ratio is 2.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 2.03, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on QScreen AI and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QScreen AI's current PEG Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QScreen AI stock overvalued right now?
QScreen AI (PMEDF) has a current PEG Ratio of 0.00. The current PEG Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For QScreen AI (PMEDF), the current PEG Ratio is 0.00 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

QScreen AI Business Description

Other Exchanges 3QP:GermanyQAI:Canada
Address 40 King Street West, Suite 2400, P.O. Box 215, Scotia Plaza, Toronto, ON, CAN, M5H 3Y2
QScreen AI Inc is focused on developing artificial intelligence (AI) powered technologies for general workplace health and safety, and for the health care industry. The company's business is focused on artificial intelligence (AI) technologies targeting two specific areas: workplace health and safety and healthcare. It is building a proprietary artificial intelligence engine with quantum inspired computing and physiological sensing to clinical and occupational health assessments across correctional facilities, addiction medicine rehabilitation, and industrial workforce screening in multiple jurisdictions. It operates in single segment.